Baricitinib vs Imatinib

Baricitinib vs Imatinib: Overview

This comparison examines the pharmacological differences between Baricitinib and Imatinib.

Mechanism of Action

Baricitinib: Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.

Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

Pharmacokinetics

Half-life: Baricitinib — 12 hours; Imatinib — 18 hours.

Chemical Properties

Molecular Formula: Baricitinib — C16H17N7O2S; Imatinib — C29H31N7O.

Molecular Weight: Baricitinib — 371.4170 g/mol; Imatinib — 493.6030 g/mol.

Type: Baricitinib — Small molecule; Imatinib — Small molecule.